Jennifer Sexton

Director/CAS Custom Services

Bio

As part of CAS Custom Services, Jennifer designs individualized client solutions by leveraging CAS content, technology, and subject matter experts to solve complex client R&D and business challenges. Jen joined CAS Custom Services in 2020 after spending over a decade as a strategic account manager. Part of her former role included writing and delivering technical customer training for the CAS STN and CAS SciFinder® software platforms.

Jennifer holds a Master of Science degree in chemistry from the University of Notre Dame. She has a Bachelor of Science degree in chemistry and a Bachelor of Arts degree in psychology from Southwest Minnesota State University. She is a member of the Patent Information Users Group (PIUG) and the American Chemical Society (ACS).

Digital R&D
Discover how artificial intelligence in pharma can enhance drug repurposing by leveraging dark data, ensuring data diversity, and improving data quality.
|Article
Read the CAS Insights article
Digital R&D
Learn how emerging trends in AI are impacting CBRNE threat detection and mitigation.
|Article
Read the CAS Insights article
Digital R&D
Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.
|Article
Read the CAS Insights article
Digital R&D
Learn how digital transformation is reducing waste and creating new revenue streams for companies as they repurpose waste byproducts.
|Article
Read the CAS Insights article
Digital R&D
Pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once-hidden knowledge into drug discoveries.
|Article
Read the CAS Insights article
Digital R&D
As the drug repurposing market grows, pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once hidden insights into drug repurposing innovations.
|Article
Read the CAS Insights article
Digital R&D
Digital initiatives are transforming the chemical industry, allowing for faster innovation and a sustainable future.
|Article
Read the CAS Insights article
Digital R&D
Strategies to unlock dark data in the pharmaceutical industry. Reveal data insights and accelerate innovation through digitization and knowledge management.
|Article
Read the CAS Insights article
Digital R&D
Digital initiatives are transforming the pharmaceutical industry, allowing for faster drug development and expanded treatment options.
|Article
Read the CAS Insights article
Digital R&D
Research and development teams amass huge quantities of complex data which, if exploited correctly, can be a useful information source to improve decision-making and drive innovation.
|Article
Read the CAS Insights article